- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 14.02. | UniSafe Device Drives Biosimilar Success in Japan | ||
| 14.02. | Sanofi, J&J Discontinue E.mbrace Study | ||
| 14.02. | Glenmark Launches Latanoprost Ophthalmic Solution | ||
| 13.02. | Biogen 4Q Results | ||
| 13.02. | Sygnature Discovery Appoints Fraser McIntosh In Vivo Pharmacology VP | ||
| 13.02. | Nutriband and Kindeva to Co-Develop Aversa Fentanyl Abuse-Deterrent Patch | ||
| 13.02. | FDA Greenlights Roche's Evrysdi Tablet | ||
| 12.02. | Bio X Cell Introduces New Distribution Center in Beijing | ||
| 12.02. | Emmes Group Earns ISO 27001:2022 Certification for Data Security | ||
| 12.02. | SK pharmteco Launches Enhanced HPAPI Analytical Testing Lab | ||
| 12.02. | AdvanCell & Lilly Expand Collaboration for Targeted Alpha Therapies | ||
| 12.02. | OliX, Lilly Enter Global Licensing Agreement for Cardiometabolic Indications | ||
| 12.02. | Axplora Invests €50M in GLP-1 Manufacturing at France Site | ||
| 12.02. | Alcami Names Tori E. Arens as President of Drug Product | ||
| 12.02. | OnCusp's CUSP06 Receives FDA Fast Track Designation | ||
| 12.02. | Lundbeck's Potential Treatment for Multiple System Atrophy Granted Fast Track Designation | ||
| 11.02. | Alloy Partners with Pfizer to Develop New Antibody Discovery Platform | ||
| 11.02. | Oramed Pharmaceuticals to Spin Off Its Protein Oral Delivery Technology | ||
| 11.02. | Roquette Launches New Coatings Platform | ||
| 11.02. | Novartis to Acquire Anthos Therapeutics | ||
| 11.02. | Telix's Illucix Approved by Danish Medicines Agency | ||
| 11.02. | Frontier Scientific Solutions Begins Construction of cGMP Temp-Controlled Facility at Wilmington International Airport | ||
| 10.02. | AbbVie's EMBLAVEO Approved by FDA for Treatment of Complicated Intra-Abdominal Infections | ||
| 10.02. | Hoth Therapeutics, OnTargetx R&D Partner to Advance Research for Cancer Therapeutic | ||
| 10.02. | Accord, Bio-Thera Partner on Simponi Biosimilar BAT2506 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
